Menu

Unity Biotechnology, Inc. UBX

Full chart Compare
Set alert

Price alert · UBX

All alert types
0.20 0.00 (+0.00%)

At closeJul 2, 2026, 4:00 PM EDT

0.2001 Day range 0.2001
0.947 52-week range 2.02
YTD
-79.51%
1 year
-84.95%

Revenue & Expenses

Other Operating Income → Expenses: $35.46MExpenses → Gross Loss: $1.94MExpenses → Selling, General & Admin: $20.95MExpenses → Research & Development: $36.86MExpenses → Other Expenses: $20.18MNet Loss → Expenses: $44.47MRevenue → Cost of Revenue: $236.00KOther Operating Income$35.46MNet Loss$44.47MCost of Revenue$2.18MExpenses$79.93MGross Loss$1.94MSelling, General & Admin$20.95MResearch & Development$36.86MOther Expenses$20.18MRevenue$236.00K

Latest period ending Dec 31, 2024 · select a line to chart its full history

UBX annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-31.17M-44.67M-57.57M-56.66M-93.93M
-25.99M-39.86M-44.47M-60.73M-93.84M
-1.54-2.70-4.68-10.88-18.45
UBX annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
7.58M19.80M12.74M33.45M17.81M
37.66M65.69M124.35M124.71M156.32M
31.17M37.29M68.27M65.14M73.44M
19.71M23.54M47.36M52.52M58.98M
6.49M28.40M56.08M59.57M82.88M
UBX annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-20.86M-37.09M-52.41M-45.06M-78.33M
8.56M60.49M-24.55M39.31M-5.21M
77.00K-16.34M56.24M20.84M63.88M
26.00K104.00K282.00K-195.00K-646.00K
-12.22M7.07M-20.72M15.10M-19.67M